drugset / Trial / NCT01345565

Hepatocyte Transplantation for Acute Decompensated Liver Failure

NCT01345565 ↗

Phase 1 Withdrawn Ira Fox
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to determine whether liver cell transplantation can provide help for patients with liver failure who are unlikely to survive without some form of liver support. The goal of this research study is to determine if liver cell transplants can be effective until a liver transplant is received or until patients recover from their liver failure.

Timeline

Start
2011-03
Primary completion
2019-01
Completion
2019-01

Outcome

Outcome not reported

Stopped (Business): “A funding mechanism is not identified at this time”

Drugs

EvaluationDrugModalityDoseRoute
Subject human hepatocytes Cell therapy — Other

Indications